Announced Fri, 26 Jun · 14:37 IST
Trading Window closed from July 1 till Q1 FY26 results
Compliance View source PDF
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.1%1-day move
₹258.00
prior close
₹256.09
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.9+0.9+1.1+2.5+7.1+3.9+3.6+2.6+0.8+2.3+3.3———
Up moveDown movePending
AI summary
Marksans Pharma has informed the exchanges that the trading window for designated persons and their immediate relatives will remain closed from Wednesday, July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026. During this period, insiders cannot trade in the company shares. The results date will be announced later. This is a routine compliance filing under SEBI Insider Trading Regulations.
Likely market impact
Routine compliance notice. Designated persons cannot trade shares until 48 hours after Q1 FY26 results are declared. No material impact for retail investors.